Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Paul Rhomberg, BS, MT(ASCP)

Drug Development Manager
JMI Laboratories

Disclosure(s): Cidara: Grant/Research Support, Grant/Research Support; Pfizer: Grant/Research Support, Grant/Research Support

Poster(s):

347 - Azole Activity against Filamentous Fungi Causing Invasive Infections in Patients from ICU and Non-ICU Units (2017-2021)
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET
1731 - Rezafungin Activity against Candida spp. and Aspergillus spp. Isolates Causing Invasive Infections Worldwide in 2021
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET